Florida Senate - 2009                                    SB 2468
       
       
       
       By Senator Villalobos
       
       
       
       
       38-01529A-09                                          20092468__
    1                        A bill to be entitled                      
    2         An act relating to asbestos and silica claims;
    3         amending s. 774.202, F.S.; revising the purpose of the
    4         Asbestos and Silica Compensation Fairness Act;
    5         amending s. 774.203, F.S.; revising definitions;
    6         amending s. 774.204, F.S.; providing that physical
    7         impairment or death is an essential element of an
    8         asbestos or silica claim; revising the requirements of
    9         a prima facie showing of physical impairment or death
   10         as a result of a medical condition to which exposure
   11         to asbestos was a contributing factor; deleting the
   12         requirements for a prima facie showing of physical
   13         impairment or death as a result of certain cancers by
   14         a smoker; providing that a prima facie showing is not
   15         required in a civil action alleging an asbestos claim
   16         based on certain cancers, including cancer of the
   17         colon, rectum, and stomach; deleting a provision that
   18         prohibits a person from filing a civil action alleging
   19         an asbestos claim that is based on cancer of the
   20         colon, rectum, or stomach in the absence of a prima
   21         facie showing; revising requirements for certain
   22         evidence relating to physical impairment; amending s.
   23         774.205, F.S.; revising requirements for bringing a
   24         civil action alleging an asbestos or silica claim in
   25         the courts of this state; amending s. 774.206, F.S.;
   26         deleting the provision that prohibits damages from
   27         being awarded for fear or risk of cancer in a civil
   28         action asserting an asbestos or silica claim; amending
   29         s. 774.207, F.S.; authorizing punitive damages to be
   30         awarded only in accordance with state law; amending s.
   31         774.208, F.S.; deleting liability rules with regard to
   32         product sellers; providing for applicability;
   33         providing an effective date.
   34  
   35         WHEREAS, asbestos is a mineral that was widely used before
   36  the mid-1970's for insulation, fireproofing, and other purposes,
   37  and
   38         WHEREAS, millions of American workers and others were
   39  exposed to asbestos, especially during and after World War II
   40  and before the advent of regulation by the Occupational Safety
   41  and Health Administration in the early 1970's, and
   42         WHEREAS, long-term exposure to asbestos has been associated
   43  with various types of cancer, including mesothelioma and lung
   44  cancer, as well as such nonmalignant conditions as asbestosis,
   45  pleural plaques, and diffuse pleural thickening, and
   46         WHEREAS, the diseases caused by asbestos often have long
   47  latency periods, and
   48         WHEREAS, although the use of asbestos has dramatically
   49  declined since the 1970's and workplace exposures have been
   50  regulated since 1971 by the Occupational Safety and Health
   51  Administration, past exposures will continue to result in
   52  significant claims of death and disability as a result of such
   53  exposure, and
   54         WHEREAS, exposure to asbestos has created a flood of
   55  litigation in state and federal courts that the United States
   56  Supreme Court in Ortiz v. Fibreboard Corporation, 119 S.Ct.
   57  2295, 2302 (1999), has characterized as an “elephantine mass” of
   58  cases that “defies customary judicial administration,” and
   59         WHEREAS, asbestos personal injury litigation can be unfair
   60  and inefficient, imposing a severe burden on litigants and
   61  taxpayers alike, and
   62         WHEREAS, the inefficiencies and societal costs of asbestos
   63  litigation have been well documented in reports such as the RAND
   64  Institutes study on Asbestos Litigation Costs and Compensation,
   65  the study of Joseph E. Stiglitz on The Impact of Asbestos
   66  Liabilities on Workers in Bankrupt Firms, Dr. Joseph Gitlin's
   67  report from Johns Hopkins Medical School on Comparison of B
   68  Readers' Interpretations of Chest Radiographs for Asbestos
   69  Related Changes, and the Report to the House of Delegates from
   70  the American Bar Association Commission on Asbestos Litigation,
   71  and
   72         WHEREAS, the vast majority of asbestos claims are filed by
   73  individuals who allege they have been exposed to asbestos and
   74  who may have some physical sign of exposure but who suffer no
   75  present asbestos-related impairment, and
   76         WHEREAS, the cost of compensating exposed individuals who
   77  are not sick jeopardizes the ability of defendants to compensate
   78  people who develop cancer and other serious asbestos-related
   79  diseases, now and in the future, and
   80         WHEREAS, the cost of compensating exposed individuals who
   81  are not sick threatens the savings, retirement benefits, and
   82  jobs of defendants' current and retired employees and adversely
   83  affects the communities in which these defendants operate, and
   84         WHEREAS, the crush of asbestos litigation has been costly
   85  to employers, employees, litigants, and the court system, and
   86         WHEREAS, in 1982, the Johns-Manville Corporation, the
   87  nation's largest single supplier of insulation products
   88  containing asbestos, declared bankruptcy due to the burden of
   89  the asbestos litigation, and
   90         WHEREAS, since 1982, more than 70 other companies have
   91  reorganized due to the burden of asbestos litigation, and
   92         WHEREAS, silica is a naturally occurring mineral, and
   93         WHEREAS, the Earth's crust is more than 90 percent silica,
   94  and crystalline silica dust is the primary component of sand,
   95  quartz, and granite, and
   96         WHEREAS, silica-related illness, including silicosis, can
   97  occur when tiny silica particles are inhaled, and
   98         WHEREAS, silicosis was recognized as an occupational
   99  disease many years ago, and
  100         WHEREAS, the American Foundrymen's Society has distributed
  101  literature for more than 100 years to its members warning of the
  102  dangers of silica exposure, and
  103         WHEREAS, the number of new lawsuits alleging silica-related
  104  disease being filed each year began to rise precipitously in
  105  recent years, and
  106         WHEREAS, silica claims, like asbestos claims, often arise
  107  when an individual is identified as having markings on his or
  108  her lungs that are possibly consistent with silica exposure but
  109  the individual has no functional or physical impairment from any
  110  silica-related disease, and
  111         WHEREAS, the Legislature finds that an overpowering public
  112  necessity requires it to act to prevent a silica-based
  113  litigation crisis, and
  114         WHEREAS, concerns about statutes of limitations may prompt
  115  claimants who have been exposed to asbestos or silica but who do
  116  not have any current injury to bring premature lawsuits in order
  117  to protect against losing their rights to future compensation
  118  should they become impaired, and
  119         WHEREAS, consolidations, joinders, and similar procedures
  120  to which some courts have resorted in order to deal with the
  121  mass of asbestos and silica cases can undermine the appropriate
  122  functioning of the judicial process and further encourage the
  123  filing of thousands of cases by exposed individuals who are not
  124  sick and who may never become sick, and
  125         WHEREAS, the Legislature finds that there is an
  126  overpowering public necessity to defer the claims of exposed
  127  individuals who are not sick in order to preserve, now and for
  128  the future, defendants' ability to compensate people who develop
  129  cancer and other serious asbestos-related and silica-related
  130  injuries and to safeguard the jobs, benefits, and savings of
  131  workers in this state and the well-being of the economy of this
  132  state, NOW, THEREFORE,
  133  
  134  Be It Enacted by the Legislature of the State of Florida:
  135  
  136         Section 1. Section 774.202, Florida Statutes, is amended to
  137  read:
  138         774.202 Purpose.—It is the purpose of this act to:
  139         (1) Ensure that persons who have demonstrable injuries as a
  140  result of exposure to asbestos and silica are given their
  141  constitutional right to access the court system; and Give
  142  priority to true victims of asbestos and silica, claimants who
  143  can demonstrate actual physical impairment caused by exposure to
  144  asbestos or silica;
  145         (2) Ensure that the burdens of medical monitoring and
  146  health care are not shifted from the asbestos and silica
  147  companies to patients in this state, health insurance companies,
  148  employers, and the Department of Financial Services. Fully
  149  preserve the rights of claimants who were exposed to asbestos or
  150  silica to pursue compensation if they become impaired in the
  151  future as a result of the exposure;
  152         (3)Enhance the ability of the judicial system to supervise
  153  and control asbestos and silica litigation; and
  154         (4)Conserve the scarce resources of the defendants to
  155  allow compensation to cancer victims and others who are
  156  physically impaired by exposure to asbestos or silica while
  157  securing the right to similar compensation for those who may
  158  suffer physical impairment in the future.
  159         Section 2. Subsections (4), (18), (22), (23), (24), (25),
  160  and (29) of section 774.203, Florida Statutes, are amended to
  161  read:
  162         774.203 Definitions.—As used in this act, the term:
  163         (4) “Asbestosis” means interstitial pneumonitis and
  164  fibrosis caused by inhalation of asbestos fibers as defined in
  165  an article entitled Diagnosis and Initial Management of Non
  166  Malignant Diseases Related to Asbestos, December 12th, 2003
  167  Official Statement of the American Thoracic Society, 170
  168  American Journal of Respiratory and Critical Care Medicine 697
  169  (2004) bilateral diffuse interstitial fibrosis of the lungs
  170  caused by inhalation of asbestos fibers.
  171         (18) “Mesothelioma” means a malignant tumor with a primary
  172  site in the pleura, or the peritoneum, the pericardium, or the
  173  tunica vaginalis testis which has been diagnosed by a board
  174  certified pathologist, using standardized and accepted criteria
  175  of microscopic morphology or appropriate staining techniques.
  176         (22) “Predicted lower limit of normal” for any test means
  177  below the reference values set by the American Thoracic Society
  178  the fifth percentile of healthy populations based on age,
  179  height, and gender, as referenced in the AMA Guides to the
  180  Evaluation of Permanent Impairment.
  181         (23) “Qualified physician” means a medical doctor, who:
  182         (a) Is a board-certified pathologist licensed to practice
  183  and actively practices in this country who performed services
  184  requested or authorized by a physician who:
  185         1. Has conducted an evaluation of pathology materials
  186  obtained from surgical or postmortem specimens a physical
  187  examination of the exposed person or, if the person is deceased,
  188  has reviewed all available records relating to the exposed
  189  person’s medical condition; and
  190         2.Is actually treating or has treated the exposed person,
  191  and has or had a doctor-patient relationship with the person;
  192  and
  193         2.3. Is licensed to practice and actively practices in this
  194  country; or
  195         (b) Is a board-certified oncologist, pulmonary specialist,
  196  or specialist in occupational and environmental medicine who:
  197         1. Has conducted a physical examination of the exposed
  198  person or, if the person is deceased, has reviewed all available
  199  records relating to the exposed person’s medical condition; and
  200         2.Is actually treating or has treated the exposed person,
  201  and has or had a doctor-patient relationship with the person;
  202  and
  203         2.3. Is licensed to practice and actively practices in this
  204  country.
  205         (24) “Radiological evidence of asbestosis” means a finding
  206  on a quality 1 chest X ray under the ILO System of
  207  classification (in a death case where no pathology is available,
  208  the necessary radiologic findings may be made with a quality 2
  209  film if a quality 1 film is not available) showing small,
  210  irregular opacities (s, t, u) graded by a certified B-reader of
  211  1/0 or higher as at least 1/1 on the ILO scale, or such other
  212  competent evidence of asbestosis on computed tomography by a
  213  licensed physician.
  214         (25) “Radiological evidence of diffuse pleural disease
  215  thickening” means a finding on a quality 1 chest X ray and
  216  computer tomography showing pleural plaques or pleural
  217  thickening, which is made by a licensed physician under the ILO
  218  System of classification (in a death case where no pathology is
  219  available, the necessary radiologic findings may be made with a
  220  quality 2 film if a quality 1 film is not available) showing
  221  bilateral pleural thickening of at least B2 on the ILO scale and
  222  blunting of at least one costophrenic angle.
  223         (29) “Smoker” means a person who has smoked cigarettes or
  224  used other tobacco products on a consistent and frequent basis
  225  within the last 5 15 years.
  226         Section 3. Section 774.204, Florida Statutes, is amended to
  227  read:
  228         774.204 Physical impairment.—
  229         (1) Physical impairment or death of the exposed person, to
  230  which asbestos or silica exposure was a substantial contributing
  231  factor, is an essential element of an asbestos or silica claim.
  232         (2) A person may not file or maintain a civil action
  233  alleging a nonmalignant asbestos claim in the absence of a prima
  234  facie showing of physical impairment or death as a result of a
  235  medical condition to which exposure to asbestos was a
  236  substantial contributing factor. The prima facie showing must
  237  include all of the following requirements:
  238         (a) Evidence verifying that a qualified physician, or
  239  someone working under the direct supervision and control of a
  240  qualified physician, has taken a detailed occupational and
  241  exposure history of the exposed person or, if the person is
  242  deceased, from a person who is knowledgeable about the exposures
  243  that form the basis of the nonmalignant asbestos claim,
  244  including:
  245         1. Identification of all of the exposed person’s pertinent
  246  principal places of employment and exposures to airborne
  247  contaminants; and
  248         2. Whether each place of employment involved exposures to
  249  airborne contaminants, including but not limited to asbestos
  250  fibers or other disease-causing dusts, that can cause pulmonary
  251  impairment and the nature, duration, and level of any such
  252  exposure, if known.
  253         (b) Evidence verifying that a qualified physician, or
  254  someone working under the direct supervision and control of a
  255  qualified physician, has taken a detailed medical and smoking
  256  history, including a thorough review of the exposed person’s
  257  past and present medical problems and their most probable cause.
  258         (c) Evidence sufficient to demonstrate that at least 10
  259  years have elapsed between the date of first exposure to
  260  asbestos and the date the diagnosis is made.
  261         (d) In the case of a living person, a determination by a
  262  qualified physician that the exposed person is impaired as
  263  defined by official statements of the American Thoracic Society,
  264  on the basis of a medical examination and pulmonary function
  265  testing, that the exposed person has a permanent respiratory
  266  impairment rating of at least Class 2 as defined by and
  267  evaluated pursuant to the AMA Guides to the Evaluation of
  268  Permanent Impairment.
  269         (e) A diagnosis by a qualified physician of asbestosis or
  270  asbestos-related pleural disease diffuse pleural thickening,
  271  based at a minimum on radiological or pathological evidence of
  272  asbestosis or radiological evidence of asbestos-related pleural
  273  disease of diffuse pleural thickening.
  274         (f) In the case of a living person, a determination by a
  275  qualified physician that asbestosis or asbestos-related pleural
  276  disease diffuse pleural thickening, rather than chronic
  277  obstructive pulmonary disease, is a substantial contributing
  278  factor to the exposed person’s physical impairment as defined by
  279  the official statements of the American Thoracic Society., based
  280  at a minimum on a determination that the exposed person has:
  281         1.Total lung capacity, by plethysmography or timed gas
  282  dilution, below the predicted lower limit of normal;
  283         2.Forced vital capacity below the lower limit of normal
  284  and a ratio of FEV1 to FVC that is equal to or greater than the
  285  predicted lower limit of normal; or
  286         3.A chest X ray showing small, irregular opacities (s, t,
  287  u) graded by a certified B-reader as at least 2/1 on the ILO
  288  scale.
  289         (g)If the exposed person meets the requirements of
  290  paragraphs (a), (b), and (c), and if a qualified physician
  291  determines that the exposed person has a physical impairment, as
  292  demonstrated by meeting the criteria set forth in paragraph (d)
  293  and subparagraph (f)1. or subparagraph (f)2., but the exposed
  294  person’s chest X ray does not demonstrate radiological evidence
  295  of asbestosis, the exposed person may meet the criteria of
  296  paragraph (e) if his or her chest X ray is graded by a certified
  297  B-reader as at least 1/0 and a qualified physician, relying on
  298  high-resolution computed tomography, determines to a reasonable
  299  degree of medical certainty that the exposed person has
  300  asbestosis and forms the conclusion set forth in paragraph (h).
  301         (g)(h) A conclusion by a qualified physician that the
  302  exposed person’s exposure to asbestos was a substantial
  303  contributing cause to the exposed person’s medical findings, and
  304  impairment, or death were not more probably the result of causes
  305  other than the asbestos exposure revealed by the exposed
  306  person’s employment and medical history. A diagnosis that states
  307  that the medical findings and impairment are “consistent with”
  308  or “compatible with” exposure to asbestos does not meet the
  309  requirements of this subsection.
  310         (h)(i) If a plaintiff files a civil action alleging a
  311  nonmalignant asbestos claim, and that plaintiff alleges that his
  312  or her exposure to asbestos was the result of extended contact
  313  with another exposed person who, if the civil action had been
  314  filed by the other exposed person, would have met the
  315  requirements of paragraph (a), and the plaintiff alleges that he
  316  or she had extended contact with the exposed person during the
  317  time period in which that exposed person met the requirements of
  318  paragraph (a), the plaintiff has satisfied the requirements of
  319  paragraph (a). The plaintiff in such a civil action must
  320  individually satisfy the requirements of paragraphs (b), (c),
  321  (d), (e), (f), (g), and (h).
  322         (3)A person who is a smoker may not file or maintain a
  323  civil action alleging an asbestos claim which is based upon
  324  cancer of the lung, larynx, pharynx, or esophagus in the absence
  325  of a prima facie showing that includes all of the following
  326  requirements:
  327         (a)A diagnosis by a qualified physician who is board
  328  certified in pathology, pulmonary medicine, or oncology, as
  329  appropriate for the type of cancer claimed, of a primary cancer
  330  of the lung, larynx, pharynx, or esophagus, and that exposure to
  331  asbestos was a substantial contributing factor to the condition.
  332         (b)Evidence sufficient to demonstrate that at least 10
  333  years have elapsed between the date of first exposure to
  334  asbestos and the date of diagnosis of the cancer.
  335         (c)Radiological or pathological evidence of asbestosis or
  336  diffuse pleural thickening or a qualified physician’s diagnosis
  337  of asbestosis based on a chest X ray graded by a certified B
  338  reader as at least 1/0 on the ILO scale and high-resolution
  339  computed tomography supporting the diagnosis of asbestosis to a
  340  reasonable degree of medical certainty.
  341         (d)Evidence of the exposed person’s substantial
  342  occupational exposure to asbestos. If a plaintiff files a civil
  343  action alleging an asbestos-related claim based on cancer of the
  344  lung, larynx, pharynx, or esophagus, and that plaintiff alleges
  345  that his or her exposure to asbestos was the result of extended
  346  contact with another exposed person who, if the civil action had
  347  been filed by the other exposed person, would have met the
  348  substantial occupational exposure requirement of this
  349  subsection, and the plaintiff alleges that he or she had
  350  extended contact with the exposed person during the time period
  351  in which that exposed person met the substantial occupational
  352  exposure requirement of this subsection, the plaintiff has
  353  satisfied the requirements of this paragraph. The plaintiff in
  354  such a civil action must individually satisfy the requirements
  355  of this subsection.
  356         (e)If the exposed person is deceased, the qualified
  357  physician, or someone working under the direct supervision and
  358  control of a qualified physician, may obtain the evidence
  359  required in paragraphs (b) and (d) from the person most
  360  knowledgeable about the alleged exposures that form the basis of
  361  the asbestos claim.
  362         (f)A conclusion by a qualified physician that the exposed
  363  person’s medical findings and impairment were not more probably
  364  the result of causes other than the asbestos exposure revealed
  365  by the exposed person’s employment and medical history. A
  366  conclusion that the medical findings and impairment are
  367  “consistent with” or “compatible with” exposure to asbestos does
  368  not meet the requirements of this subsection.
  369         (3)(4) In a civil action alleging an asbestos claim by a
  370  nonsmoker based on cancer of the lung, larynx, pharynx, colon,
  371  rectum, stomach, or esophagus, a prima facie showing of an
  372  impairment due to asbestos exposure is not required.
  373         (5)A person may not file or maintain a civil action
  374  alleging an asbestos claim which is based on cancer of the
  375  colon, rectum, or stomach in the absence of a prima facie
  376  showing that includes all of the following requirements:
  377         (a)A diagnosis by a qualified physician who is board
  378  certified in pathology, pulmonary medicine, or oncology, as
  379  appropriate for the type of cancer claimed, of cancer of the
  380  colon, rectum, or stomach, and that exposure to asbestos was a
  381  substantial contributing factor to the condition.
  382         (b)Evidence sufficient to demonstrate that at least 10
  383  years have elapsed between the date of first exposure to
  384  asbestos and the date of diagnosis of the cancer.
  385         (c)1.a.Radiological or pathological evidence of asbestosis
  386  or diffuse pleural thickening or a qualified physician’s
  387  diagnosis of asbestosis based on a chest X ray graded by a
  388  certified B-reader as at least 1/0 on the ILO scale and high
  389  resolution computed tomography supporting the diagnosis of
  390  asbestosis to a reasonable degree of medical certainty; or
  391         b.Evidence of the exposed person’s substantial
  392  occupational exposure to asbestos. If a plaintiff files a civil
  393  action alleging an asbestos-related claim based on cancer of the
  394  colon, rectum, or stomach, and that plaintiff alleges that his
  395  or her exposure to asbestos was the result of extended contact
  396  with another exposed person who, if the civil action had been
  397  filed by the other exposed person, would have met the
  398  substantial occupational exposure requirement of this
  399  subsection, and the plaintiff alleges that he or she had
  400  extended contact with the exposed person during the time period
  401  in which that exposed person met the substantial occupational
  402  exposure requirement of this subsection, the plaintiff has
  403  satisfied the requirements of this sub-subparagraph. The
  404  plaintiff in such a civil action must individually satisfy the
  405  requirements of this subsection.
  406         2.In the case of an exposed person who is a smoker, the
  407  criteria in sub-subparagraph 1.a. and b. must be met.
  408         3.If the exposed person is deceased, the qualified
  409  physician, or someone working under the direct supervision and
  410  control of a qualified physician, may obtain the evidence
  411  required in sub-subparagraph 1.b. and paragraph (b) from the
  412  person most knowledgeable about the alleged exposures that form
  413  the basis of the asbestos claim.
  414         (d)A conclusion by a qualified physician that the exposed
  415  person’s medical findings and impairment were not more probably
  416  the result of causes other than the asbestos exposure revealed
  417  by the exposed person’s employment and medical history. A
  418  conclusion that the medical findings and impairment are
  419  “consistent with” or “compatible with” exposure to asbestos does
  420  not meet the requirements of this subsection.
  421         (4)(6) In a civil action alleging an asbestos claim based
  422  upon mesothelioma a prima facie showing of an impairment due to
  423  asbestos exposure is not required.
  424         (5)(7) A person may not file or maintain a civil action
  425  alleging a silicosis claim in the absence of a prima facie
  426  showing of physical impairment as a result of a medical
  427  condition to which exposure to silica was a substantial
  428  contributing factor. The prima facie showing must include all of
  429  the following requirements:
  430         (a) Evidence verifying that a qualified physician, or
  431  someone working under the direct supervision and control of a
  432  qualified physician, has taken a detailed occupational and
  433  exposure history of the exposed person or, if the person is
  434  deceased, from a person who is knowledgeable about the exposures
  435  that form the basis of the nonmalignant silica claim, including:
  436         1. All of the exposed person’s principal places of
  437  employment and exposures to airborne contaminants; and
  438         2. Whether each place of employment involved exposures to
  439  airborne contaminants, including, but not limited to, silica
  440  particles or other disease-causing dusts, that can cause
  441  pulmonary impairment and the nature, duration, and level of any
  442  such exposure.
  443         (b) Evidence verifying that a qualified physician, or
  444  someone working under the direct supervision and control of a
  445  qualified physician, has taken detailed medical and smoking
  446  history, including a thorough review of the exposed person’s
  447  past and present medical problems and their most probable cause,
  448  and verifying a sufficient latency period for the applicable
  449  stage of silicosis.
  450         (c) A determination by a qualified physician, on the basis
  451  of a medical examination and pulmonary function testing, that
  452  the exposed person has a permanent respiratory impairment rating
  453  of at least Class 2 as defined by and evaluated pursuant to the
  454  AMA Guides to the Evaluation of Permanent Impairment.
  455         (d) A determination by a qualified physician that the
  456  exposed person has:
  457         1. A quality 1 chest X ray under the ILO System of
  458  classification and that the X ray has been read by a certified
  459  B-reader as showing, according to the ILO System of
  460  classification, bilateral nodular opacities (p, q, or r)
  461  occurring primarily in the upper lung fields, graded 1/1 or
  462  higher; or
  463         2. Pathological demonstration of classic silicotic nodules
  464  exceeding one centimeter in diameter as published in 112 Archive
  465  of Pathology and Laboratory Medicine 7 (July 1988).
  466  
  467  In a death case where no pathology is available, the necessary
  468  radiologic findings may be made with a quality 2 film if a
  469  quality 1 film is not available.
  470         (e) A conclusion by a qualified physician that the exposed
  471  person’s medical findings and impairment were not more probably
  472  the result of causes other than silica exposure revealed by the
  473  exposed person’s employment and medical history. A conclusion
  474  that the medical findings and impairment are “consistent with”
  475  or “compatible with” exposure to silica does not meet the
  476  requirements of this subsection.
  477         (6)(8) A person may not file or maintain a civil action
  478  alleging a silica claim other than as provided in subsection (5)
  479  (7), in the absence of a prima facie showing that includes all
  480  of the following requirements:
  481         (a) A report by a qualified physician who is:
  482         1. Board certified in pulmonary medicine, internal
  483  medicine, oncology, or pathology stating a diagnosis of the
  484  exposed person of silica-related lung cancer and stating that,
  485  to a reasonable degree of medical probability, exposure to
  486  silica was a substantial contributing factor to the diagnosed
  487  lung cancer; or
  488         2. Board certified in pulmonary medicine, internal
  489  medicine, or pathology stating a diagnosis of the exposed person
  490  of silica-related progressive massive fibrosis or acute
  491  silicoproteinosis, or silicosis complicated by documented
  492  tuberculosis.
  493         (b) Evidence verifying that a qualified physician, or
  494  someone working under the direct supervision and control of a
  495  qualified physician, has taken a detailed occupational and
  496  exposure history of the exposed person or, if the person is
  497  deceased, from a person who is knowledgeable about the exposures
  498  that form the basis of the nonmalignant silica claim, including:
  499         1. All of the exposed person’s principal places of
  500  employment and exposures to airborne contaminants; and
  501         2. Whether each place of employment involved exposures to
  502  airborne contaminants, including, but not limited to, silica
  503  particles or other disease-causing dusts, that can cause
  504  pulmonary impairment and the nature, duration, and level of any
  505  such exposure.
  506         (c) Evidence verifying that a qualified physician, or
  507  someone working under the direct supervision and control of a
  508  qualified physician, has taken a detailed medical and smoking
  509  history, including a thorough review of the exposed person’s
  510  past and present medical problems and their most probable cause;
  511         (d) A determination by a qualified physician that the
  512  exposed person has:
  513         1. A quality 1 chest X ray under the ILO System of
  514  classification and that the X ray has been read by a certified
  515  B-reader as showing, according to the ILO System of
  516  classification, bilateral nodular opacities (p, q, or r)
  517  occurring primarily in the upper lung fields, graded 1/1 or
  518  higher; or
  519         2. Pathological demonstration of classic silicotic nodules
  520  exceeding one centimeter in diameter as published in 112 Archive
  521  of Pathology and Laboratory Medicine 7 (July 1988).
  522  
  523  In a death case where no pathology is available, the necessary
  524  radiologic findings may be made with a quality 2 film if a
  525  quality 1 film is not available.
  526         (e) A conclusion by a qualified physician that the exposed
  527  person’s medical findings and impairment were not more probably
  528  the result of causes other than silica exposure revealed by the
  529  exposed person’s employment and medical history. A conclusion
  530  that the medical findings and impairment are “consistent with”
  531  or “compatible with” exposure to silica does not meet the
  532  requirements of this subsection.
  533         (7)(9) Evidence relating to physical impairment under this
  534  section, including pulmonary function testing and diffusing
  535  studies, must:
  536         (a) Comply with the official statements of the American
  537  Thoracic Society technical recommendations for examinations,
  538  testing procedures, quality assurance, quality control, and
  539  equipment of the AMA Guides to the Evaluation of Permanent
  540  Impairment, as set forth in 20 C.F.R. part 404, Subpart P. App.
  541  1. Part A, s. 3.00 E. and F., and the interpretive standards,
  542  set forth in the official statement of the American Thoracic
  543  Society entitled “lung function testing: selection of reference
  544  values and interpretive strategies” as published in American
  545  Review of Respiratory Disease. 1991: 144:1202-1218;
  546         (b) Not be obtained through testing or examinations that
  547  violate any applicable law, regulation, licensing requirement,
  548  or medical code of practice; and
  549         (c) Not be obtained under the condition that the exposed
  550  person retain legal services in exchange for the examination,
  551  test, or screening.
  552         (8)(10) Presentation of prima facie evidence meeting the
  553  requirements of subsection (2), subsection (3), subsection (5),
  554  or subsection (4) (6) of this section may not:
  555         (a) Result in any presumption at trial that the exposed
  556  person is impaired by an asbestos-related or silica-related
  557  condition;
  558         (b) Be conclusive as to the liability of any defendant; and
  559         (c) Be admissible at trial.
  560         Section 4. Section 774.205, Florida Statutes, is amended to
  561  read:
  562         774.205 Claimant proceedings.—
  563         (1)A civil action alleging an asbestos or silica claim may
  564  be brought in the courts of this state if the plaintiff is
  565  domiciled in this state or the exposure to asbestos or silica
  566  that is a substantial contributing factor to the physical
  567  impairment of the plaintiff on which the claim is based occurred
  568  in this state.
  569         (1)(2) A plaintiff in a civil action alleging an asbestos
  570  or silica claim must include with the complaint or other initial
  571  pleading a written report and supporting test results
  572  constituting prima facie evidence of the exposed person’s
  573  asbestos-related or silica-related physical impairment meeting
  574  the requirements of s. 774.204(2), (3), (5), or (6). For any
  575  asbestos or silica claim pending on the effective date of this
  576  act, the plaintiff must file the report and supporting test
  577  results at least 30 days before setting a date for trial. The
  578  defendant must be afforded a reasonable opportunity to challenge
  579  the adequacy of the proffered prima facie evidence of asbestos
  580  related impairment. The claim of the plaintiff shall be
  581  dismissed without prejudice upon a finding of failure to make
  582  the required prima facie showing.
  583         (2)(3) All asbestos claims and silica claims filed in this
  584  state on or after the effective date of this act must include,
  585  in addition to the written report described in subsection (2)
  586  and the information required by s. 774.207(2), a sworn
  587  information form containing the following information:
  588         (a) The claimant’s name, address, date of birth, and
  589  marital status;
  590         (b)If the claimant alleges exposure to asbestos or silica
  591  through the testimony of another person or alleges other than
  592  direct or bystander exposure to a product, the name, address,
  593  date of birth, and marital status for each person by which the
  594  claimant alleges exposure, hereinafter the “index person,” and
  595  the claimant’s relationship to each such person;
  596         (c)The specific location of each alleged exposure;
  597         (d)The beginning and ending dates of each alleged exposure
  598  as to each asbestos product or silica product for each location
  599  at which exposure allegedly took place for the plaintiff and
  600  each index person;
  601         (e)The occupation and name of the employer of the exposed
  602  person at the time of each alleged exposure;
  603         (b)(f) The specific condition related to asbestos or silica
  604  claimed to exist; and
  605         (c)(g) Any supporting documentation of the condition
  606  claimed to exist.
  607         Section 5. Subsections (2) and (3) of section 774.206,
  608  Florida Statutes, are amended to read:
  609         774.206 Statute of limitations; two-disease rule.—
  610         (2) An asbestos or silica claim arising out of a
  611  nonmalignant condition shall be a distinct cause of action from
  612  an asbestos or silica claim relating to the same exposed person
  613  arising out of asbestos-related or silica-related cancer.
  614  Damages may not be awarded for fear or risk of cancer in a civil
  615  action asserting an asbestos or silica claim.
  616         (3) A settlement of a nonmalignant asbestos or silica claim
  617  concluded after the effective date of this act shall may not
  618  require, as a condition of settlement, the release of any future
  619  claim for asbestos-related or silica-related cancer.
  620         Section 6. Section 774.207, Florida Statutes, is amended to
  621  read:
  622         774.207 Scope of liability; damages.—
  623         (1) Punitive damages may not be awarded only in any civil
  624  action alleging an asbestos or silica claim in accordance with
  625  the laws of this state.
  626         (2) At the time a complaint is filed in a civil action
  627  alleging an asbestos or silica claim, the plaintiff must file a
  628  verified written report with the court which discloses the total
  629  amount of any collateral source payments received, including
  630  payments that the plaintiff will receive in the future, as a
  631  result of settlements or judgments based upon the same claim.
  632  For any asbestos or silica claim pending on the effective date
  633  of this act, the plaintiff shall file a verified written report
  634  within 60 days after the effective date of this act, or at least
  635  30 days before trial. Further, the plaintiff must update the
  636  reports on a regular basis during the course of the proceeding
  637  until a final judgment is entered in the case. The court shall
  638  permit setoff, based on the collateral source payment
  639  information provided, in accordance with the laws of this state
  640  as of the effective date of this act.
  641         Section 7. Section 774.208, Florida Statutes, is amended to
  642  read:
  643         774.208 Liability rules applicable to protect sellers,
  644  renters, and lessors.—
  645         (1)(a)In a civil action alleging an asbestos or silica
  646  claim, a product seller other than a manufacturer is liable to a
  647  plaintiff only if the plaintiff establishes that:
  648         1.a.The product that allegedly caused the harm that is the
  649  subject of the complaint was sold, rented, or leased by the
  650  product seller;
  651         b.The product seller failed to exercise reasonable care
  652  with respect to the product; and
  653         c.The failure to exercise reasonable care was a proximate
  654  cause of the harm to the exposed person;
  655         2.a.The product seller made an express warranty applicable
  656  to the product that allegedly caused the harm that is the
  657  subject of the complaint, independent of any express warranty
  658  made by the manufacturer as to the same product;
  659         b.The product failed to conform to the warranty; and
  660         c.The failure of the product to conform to the warranty
  661  caused the harm to the exposed person; or
  662         3.a.The product seller engaged in intentional wrongdoing,
  663  as determined under the law of this state; and
  664         b.The intentional wrongdoing caused the harm that is the
  665  subject of the complaint.
  666         (b)For the purpose of sub-subparagraph (a)1.b., a product
  667  seller may not be considered to have failed to exercise
  668  reasonable care with respect to a product based upon an alleged
  669  failure to inspect the product, if:
  670         1.The failure occurred because there was no reasonable
  671  opportunity to inspect the product; or
  672         2.The inspection, in the exercise of reasonable care,
  673  would not have revealed the aspect of the product which
  674  allegedly caused the exposed person’s impairment.
  675         (2) In a civil action alleging an asbestos or silica claim,
  676  a person engaged in the business of renting or leasing a product
  677  is not liable for the tortious act of another solely by reason
  678  of ownership of that product.
  679         Section 8. Because this act expressly preserves the right
  680  of all injured persons to recover full compensatory damages for
  681  their loss, this act does not impair vested rights. In addition,
  682  because this act enhances the ability of the most seriously ill
  683  to receive a prompt recovery, it is remedial in nature.
  684  Therefore, this act applies to any civil action asserting an
  685  asbestos claim in which trial has not commenced as of July 1,
  686  2009.
  687         Section 9. This act shall take effect July 1, 2009.